Data from the phase 3 BOND-003 trial (NCT04452591), presented at the 2025 American Urological Association Annual Meeting, demonstrated that intravesical cretostimogene grenadenorepvec (CG0070) is a ...

Cretostimogene grenadenorepvec is an investigational oncolytic immunotherapy that is being studied for the treatment of bladder cancer, particularly non-muscle invasive bladder cancer (NMIBC) that is ...

The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others.

Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...

The ongoing phase 2b SunRISe-1 study is assessing TAR-200 intravesical gemcitabine delivery in patients with BCG-unresponsive high-risk NMIBC.

Nonbenzodiazepine MRs may improve pain, muscle spasms, and physical outcomes compared with placebo in adults with acute LBP.

TREATMENT options for stress urinary incontinence (SUI) in women have evolved significantly in recent years, particularly ...